Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
BACKGROUND: Serum 25-hydroxyvitamin D3 (Vitamin D) insufficiency and single-nucleotide polymorphisms (SNPs) on its receptor, Vitamin D receptor (VDR), have been reported to be involved in melanoma susceptibility in populations mostly from northern countries. OBJECTIVE: To investigate 25-hydroxyvitamin D3 levels and VDR SNPs in melanoma patients from sunny area of Barcelona, two studies were carried out. The first study evaluated the levels of Vitamin D at time of melanoma diagnosis and the second one analyzed the association between VDR genetic variants and risk of having a high nevus number, the strongest phenotypic risk factor for melanoma. METHODS: The levels of 25-hydroxyvitamin D3 in 81 melanoma patients at diagnosis were measured. In a second group of melanoma patients, including 150 with low and 113 with high nevus number, 11 VDR SNPs were analyzed for their association with nevus number. RESULTS: In the first study, 68% of patients had insufficient levels of 25-hydroxyvitamin D3 (<25 ng/ml). Autumn-winter months and fair phototype were associated with 25-hydroxyvitamin D3 insufficiency; after multivariate analysis, season of sampling remained the only independent predictor of 25-hydroxyvitamin D3 levels. In the second study, VDR variant rs2189480 (P = 0.006) was associated with risk of high nevus number whereas rs2239179 (P = 0.044) and rs7975128 (P = 0.0005) were protective against high nevus number. After Bonferroni adjustment only rs7975128 remained significant. In stratified analysis, SNP rs7975128 was found protective against multiple melanomas (P = 0.021). CONCLUSION: This study showed that even in Barcelona, a sunny Mediterranean area, 25-hydroxyvitamin D3 levels were sub-optimal in the majority of melanoma patients at diagnosis. The involvement of VDR in nevi and, in turn, in melanoma susceptibility has also been suggested. Larger studies are needed to confirm our findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In several studies, normal serum levels of vitamin D3 at the time of diagnosis correlate with a better prognosis136,137.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [136]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026 · cited 1×
“2011 The IOM committee reported guidelines stating that a level of 25-hydroxyvitamin D3 >20 ng/ml is needed for good bone and general health for practically all individuals [37].”
BackgroundNorman, A. W. (1979) · Cited by 3,769
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198 · cited 2×
“The skin exposure to UVB induces the photolytic conversion of 7-dehydrocholesterol (7-DHC) to previtamin D and from there to vitamin D3.”
BackgroundEfficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688
Genetics and biology of vitamin D receptor polymorphisms
Uitterlinden, A. G., Fang, Y., van Meurs, J. B. J., Pols, H. A. P., & van Leeuwen, J. P. T. M. (2004) · Gene · doi:10.1016/j.gene.2004.05.014 · Cited by 1,539 · cited 1×
“11, has more than 200 single-nucleotide polymorphisms (SNPs) [14] but only a few SNPs, considered to be functional [15], have been studied for their potential associations with melanoma susceptibility [16-21].”
BackgroundMeta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266 · cited 1×
“Sunburn and intermittent sun exposure are the most important environmental risk factors for melanoma [7] but sun exposure is also the main source for 25hydroxyvitamin D3 photosynthesis.”
BackgroundLips, P. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.016 · Cited by 1,173 · cited 1×
“where the parathyroid hormone has its maximum inhibition [34].”
BackgroundDusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
The Role of Vitamin D in Cancer Prevention
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.045260 · Cited by 1,031
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Caini, S., Boniol, M., Tosti, G., Magi, S., Medri, M., Stanganelli, I., Palli, D., Assedi, M., del Mármol, V., & Gandini, S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.024 · Cited by 133
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Slominski, R. M., Kim, T., Janjetović, Z., Brożyna, A. A., Podgórska, E., Dixon, K. M., Mason, R. S., Tuckey, R. C., Sharma, R., Crossman, D. K., et al. (2024) · Cancers · doi:10.3390/cancers16122262 · Cited by 85
Potrony, M., Puig‐Butillé, J. A., Aguilera, P., Bádenas, C., Tell‐Martí, G., Carrera, C., Pozo, L. J. D., Conejo‐Mir, J., Malvehy, J., & Puig, S. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4356 · Cited by 52
Self-citation
Metadata
- Authors
- Ogbah, Z., Visa, L., Badenas, C., Ríos, J., Puig-Butille, J. A., Bonifaci, N., Guino, E., Augé, J. M., Kolm, I., Carrera, C., Pujana, M. Á., Malvehy, J., & Puig, S.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Ogbah, Zighereda
- Puig, Susana
- Venue
- BMC Medical Genetics
- Published
- 2013-02-16
- Volume
- 14
- Issue
- 1
- Pages
- 26-26
- ISSN
- 1471-2350 (ISSN-L)
- PMC
- PMC3648347
- OpenAlex
- W2089699649
- Cited by
- 28
- References
- 56
- Citations by year
- 2024: 3 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 2
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medical Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- University of Leeds
- European Commission (LSHC‐CT‐2006‐018702)
- National Institutes of Health
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- National Cancer Institute (CA83115, R01CA083115)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanoma, 25-hydroxyvitamin D3, vitamin D insufficiency, vitamin D receptor, melanoma susceptibility, seasonal variation, phototype, Mediterranean populations
- MeSH terms
- Adult, Aged, Calcifediol, Female, Humans, Male, Melanoma, Middle Aged, Nevus, Phenotype, Retrospective Studies, Risk Factors, Seasons, Skin Neoplasms, Spain, Urban Population, Genetic Variation, Vitamin D, Vitamin D Deficiency, Cohort Studies, Receptors, Calcitriol, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona. https://app.cochat.ai/papers/10.1186/1471-2350-14-26
- The paper
- Ogbah, Z., Visa, L., Badenas, C., Ríos, J., Puig-Butille, J. A., Bonifaci, N., Guino, E., Augé, J. M., Kolm, I., Carrera, C., Pujana, M. Á., Malvehy, J., & Puig, S. (2013). Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona. BMC Medical Genetics. https://doi.org/10.1186/1471-2350-14-26
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
